Global Globin Network Consensus Paper: Classification and Stratified Roadmaps for Improved Thalassaemia Care and Prevention in 32 Countries
Hashim Halim‐Fikri(Universiti Sains Malaysia), Coralea Stephanou(Agruicultural Research Institute), Domenico Coviello(Istituto Giannina Gaslini), Narazah Mohd Yusoff(Universiti Sains Malaysia), Marina Kleanthous(Cyprus Institute of Neurology and Genetics), Petros Kountouris(Cyprus Institute of Neurology and Genetics), John Burn(Newcastle University), Jacques Élion(Délégation Paris 7), Catherine Lynn T. Silao(University of the Philippines Manila), Norafiza Mohd Yasin(Institute for Medical Research), Julia A. Hasler(Unknown), Raja-Zahratul-Azma Raja-Sabudin(University Kebangsaan Malaysia Medical Centre), Amanda Krause(National Health Laboratory Service), Chris Arnold, Nurul Fatihah Azman(Universiti Sains Malaysia), Ezalia Esa(Institute for Medical Research), Ghada El‐Kamah(National Research Centre), Wardah Yusof(Universiti Sains Malaysia), Atif Amin Baig(Management and Science University), Sharifah-Nany Rahayu-Karmilla Syed-Hassan(Universiti Sains Malaysia), Norunaluwar Jalil, Veena Selvaratnam(KPJ Ampang Puteri Specialist Hospital), Raj Ramesar, Suthat Fucharoen(Mahidol University), Helen M. Robinson(The University of Melbourne), Bin Alwi Zilfalil(Universiti Sains Malaysia), Nik Norliza Nik Hassan(Universiti Sains Malaysia), Ramdan Panigoro(Padjadjaran University), Vip Viprakasit(Siriraj Hospital), Zarina Abdul Latiff(National University of Malaysia), Carsten W. Lederer(Cyprus Institute of Neurology and Genetics), Diana Rashid(Universiti Sains Malaysia), Norsarwany Mohamad(Universiti Sains Malaysia), Rosnah Bahar(Universiti Sains Malaysia)
Cited by 20
Related Papers
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.1k
Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study
|The Lancet Global Health|2020|1.3k
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k